{"title":"十氢萘对Sprague Dawley大鼠生殖发育毒性筛选(OECD TG 421)和一代生殖毒性扩展研究(OECD TG 443)","authors":"John M. Rogers, Melissa M. Heintz, Laurie C. Haws","doi":"10.1016/j.yrtph.2025.105829","DOIUrl":null,"url":null,"abstract":"<div><div>Decahydronaphthalene (DHN), an industrial solvent, was evaluated in OECD TG 421 and TG 443 reproductive toxicity studies in Sprague Dawley rats. In the TG 421, oral doses were 0, 100, 300, or 1000 mg DHN/kg/day. In the TG 443, initial doses of 0, 30, 100, or 300 mg/kg/day were increased to 0, 60, 200, and 600 mg/kg/day on test day 30. High dose TG 421 females exhibited estrous cycle disruption; mid and high dose dams had fewer implantations and pups/litter. High dose F0 females in the TG 443 showed signs of stress: lower body weight, disrupted estrous cycling, higher adrenal and lower thymus weights, adrenocortical hypertrophy and thymic atrophy; these effects were less severe at the mid dose. High and mid dose TG 443 F0 females also had fewer implantations and pups per litter and lower litter weight. F1 females in the TG 443 had nominally fewer F2 pups and lower litter weight. The reproductive effects of DHN indicate impaired ovarian function. Mid and high dose F0 dams in the TG 443 showed clear signs of stress, to which the ovary is known to be sensitive. Therefore, DHN's effects are considered secondary to maternal stress, and not relevant to humans.</div></div>","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"160 ","pages":"Article 105829"},"PeriodicalIF":3.0000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reproductive and developmental toxicity screen (OECD TG 421) and extended one generation reproductive toxicity study (OECD TG 443) of decahydronaphthalene in Sprague Dawley rats\",\"authors\":\"John M. Rogers, Melissa M. Heintz, Laurie C. Haws\",\"doi\":\"10.1016/j.yrtph.2025.105829\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Decahydronaphthalene (DHN), an industrial solvent, was evaluated in OECD TG 421 and TG 443 reproductive toxicity studies in Sprague Dawley rats. In the TG 421, oral doses were 0, 100, 300, or 1000 mg DHN/kg/day. In the TG 443, initial doses of 0, 30, 100, or 300 mg/kg/day were increased to 0, 60, 200, and 600 mg/kg/day on test day 30. High dose TG 421 females exhibited estrous cycle disruption; mid and high dose dams had fewer implantations and pups/litter. High dose F0 females in the TG 443 showed signs of stress: lower body weight, disrupted estrous cycling, higher adrenal and lower thymus weights, adrenocortical hypertrophy and thymic atrophy; these effects were less severe at the mid dose. High and mid dose TG 443 F0 females also had fewer implantations and pups per litter and lower litter weight. F1 females in the TG 443 had nominally fewer F2 pups and lower litter weight. The reproductive effects of DHN indicate impaired ovarian function. Mid and high dose F0 dams in the TG 443 showed clear signs of stress, to which the ovary is known to be sensitive. Therefore, DHN's effects are considered secondary to maternal stress, and not relevant to humans.</div></div>\",\"PeriodicalId\":20852,\"journal\":{\"name\":\"Regulatory Toxicology and Pharmacology\",\"volume\":\"160 \",\"pages\":\"Article 105829\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regulatory Toxicology and Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0273230025000595\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, LEGAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0273230025000595","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
Reproductive and developmental toxicity screen (OECD TG 421) and extended one generation reproductive toxicity study (OECD TG 443) of decahydronaphthalene in Sprague Dawley rats
Decahydronaphthalene (DHN), an industrial solvent, was evaluated in OECD TG 421 and TG 443 reproductive toxicity studies in Sprague Dawley rats. In the TG 421, oral doses were 0, 100, 300, or 1000 mg DHN/kg/day. In the TG 443, initial doses of 0, 30, 100, or 300 mg/kg/day were increased to 0, 60, 200, and 600 mg/kg/day on test day 30. High dose TG 421 females exhibited estrous cycle disruption; mid and high dose dams had fewer implantations and pups/litter. High dose F0 females in the TG 443 showed signs of stress: lower body weight, disrupted estrous cycling, higher adrenal and lower thymus weights, adrenocortical hypertrophy and thymic atrophy; these effects were less severe at the mid dose. High and mid dose TG 443 F0 females also had fewer implantations and pups per litter and lower litter weight. F1 females in the TG 443 had nominally fewer F2 pups and lower litter weight. The reproductive effects of DHN indicate impaired ovarian function. Mid and high dose F0 dams in the TG 443 showed clear signs of stress, to which the ovary is known to be sensitive. Therefore, DHN's effects are considered secondary to maternal stress, and not relevant to humans.
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)